Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02200757
Title Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors CytRx
Age Groups: adult
Covered Countries USA | ESP

No variant requirements are available.